cannabis indica

Insônia e Distúrbios do Sono

termo de indexação original: Insomnia and Sleep Disorders

O acervo do Cannabis Indica reúne 296 estudos científicos que tocam a condição Insônia e Distúrbios do Sono, publicados entre 1839 e 2024. Pela leitura automatizada, 216 (73%) foram classificados como favoráveis, 46 (16%) como inconclusivos e 34 (11%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (147 estudos), seguido de ensaio clínico (46). Os compostos mais presentes são Tetraidrocanabinol (THC), THC Farmacêutico e THC:CBD Farmacêutico. Aparece com frequência ao lado de Ansiedade, Dor e Depressão.

Estudos indexados
296
Período coberto
1839–2024
Favoráveis
216 · 73%
Inconclusivos
46 · 16%
Desfavoráveis
34 · 11%
Termo original
Insomnia and Sleep Disorders

O acervo em números

Tipo de estudo

Metanálise147
Ensaio Clínico46
Ensaio Clínico Duplo-Cego45
Metanálise Clínica29
Estudo em Animais24
Estudo Laboratorial5

Direção do resultado

Favorável216
Inconclusivo46
Desfavorável34

Por década

1830s1
1840s1
1890s1
1910s1
1970s6
1980s2
1990s1
2000s10
2010s69
2020s204

296 estudos

Filtrar e buscar no acervo →
  1. 2024

    An intervention based on Well-Being Therapy to prevent alcohol use and other unhealthy lifestyle behaviors among students: a three-arm cluster randomized controlled trial

  2. 2024

    Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry

    FavorávelMetanáliseDorAnsiedadeArtriteTHC FarmacêuticoTHC:CBD Farmacêutico+1
  3. 2024

    Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing

    InconclusivoEnsaio ClínicoCanabidiol (CBD)
  4. 2024

    Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity-A Randomized, Double-Blind Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDisfunção Temporomandibular (DTM)CBD Farmacêutico
  5. 2024

    Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDisfunção Cognitiva
  6. 2024

    Evaluating the Impact of Probiotic Therapy on the Endocannabinoid System, Pain, Sleep and Fatigue: A Randomized, Double-Blind, Placebo-Controlled Trial in Dancers

    FavorávelEnsaio Clínico Duplo-CegoDorEndocanabinoide (não especificado)Proteína Ligadora de Ácidos Graxos (FABP)+3
  7. 2024

    Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoTEPT+2
  8. 2024

    Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaDoenças Neurodegenerativas+1
  9. 2024

    Sleep quality of adult recreational cannabis users: a systematic review of literature

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  10. 2024

    The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial

    FavorávelEnsaio Clínico Duplo-CegoDorQualidade de VidaPalmitoiletanolamida (PEA)
  11. 2024

    The Interplay of Sleep Quality, Mental Health, and Sociodemographic and Clinical Factors among Italian College Freshmen

    DesfavorávelEnsaio ClínicoDependência QuímicaAnsiedadeDepressão+2
  12. 2024

    Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research

  13. 2023

    A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality

    FavorávelEnsaio Clínico Duplo-CegoCanabinol (CBN)
  14. 2023

    A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    FavorávelEnsaio ClínicoDorAnsiedadeTetraidrocanabinol (THC)Canabinol (CBN)
  15. 2023

    A systematic review and meta-analysis of the association between young adults' sleep habits and substance use, with a focus on self-medication behaviours

  16. 2023

    Alleviation of Pain, PAIN Interference, and Oxidative Stress by a Novel Combination of Hemp Oil, Calamari Oil, and Broccoli: A Randomized, Double-Blind, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaInflamaçãoÔmega-3+2
  17. 2023

    An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry

    FavorávelMetanáliseDependência QuímicaAnsiedadeDependência — Opioides+1
  18. 2023

    An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry

    FavorávelMetanáliseDorAnsiedadeDepressão+1
  19. 2023

    Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  20. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  21. 2023

    Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides+3
  22. 2023

    Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use

  23. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  24. 2023

    Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns

    FavorávelEnsaio ClínicoDorDepressão
  25. 2023

    Cannabis use for exercise recovery in trained individuals: a survey study

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisExercício Físico+1
  26. 2023

    Cannabis use for medical symptoms: Patterns over the first year of use

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+2
  27. 2023

    CBD-oil as a potential solution in case of severe tamoxifen-related side effects

    FavorávelEnsaio ClínicoDorCâncerCâncer — Mama+2
  28. 2023

    Cognitive behavioral therapy for insomnia to reduce cannabis use: Results from a pilot randomized controlled trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  29. 2023

    Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership

    DesfavorávelEnsaio ClínicoDorDependência QuímicaEfeitos Adversos da Cannabis+3
  30. 2023

    Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions

    FavorávelMetanálise
  31. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  32. 2023

    Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  33. 2023

    Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets

    DesfavorávelEstudo em AnimaisAnsiedadeDepressãoDisfunção CognitivaEndocanabinoide (não especificado)+1
  34. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+16
  35. 2023

    Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression

    InconclusivoMetanálise ClínicaCâncerAnsiedadeDepressão+1
  36. 2023

    The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials

    FavorávelMetanálise ClínicaAnsiedadeDepressãoTEPTTetraidrocanabinol (THC)CBD Farmacêutico
  37. 2023

    The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Hipertensão Arterial
  38. 2023

    The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseCanabinol (CBN)Canabicromeno (CBC)
  39. 2023

    The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

    FavorávelMetanálise ClínicaDorDependência QuímicaAnsiedade+2
  40. 2023

    Use of Cannabidiol in the Management of Insomnia: A Systematic Review

    FavorávelMetanálise ClínicaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  41. 2022

    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

    FavorávelMetanáliseDorCâncerAnsiedade+5
  42. 2022

    A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

    InconclusivoEnsaio Clínico Duplo-CegoTranstornos de ComportamentoAutismoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  43. 2022

    A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAnandamida (AEA)Palmitoiletanolamida (PEA)+5
  44. 2022

    A survey of medical cannabis use during perimenopause and postmenopause

  45. 2022

    Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy

    InconclusivoEstudo LaboratorialAnsiedadeDepressãoGestação+1
  46. 2022

    An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample

    FavorávelMetanáliseAnsiedadeDepressão
  47. 2022

    An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry

    FavorávelEnsaio ClínicoDorEfeitos Adversos da CannabisAnsiedade+3
  48. 2022

    Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives

  49. 2022

    Ayahuasca-Induced Psychosis: A Case Report

    DesfavorávelMetanálisePsicoseAyahuasca
  50. 2022

    Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

  51. 2022

    Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

  52. 2022

    Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study

  53. 2022

    Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department

  54. 2022

    Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

    FavorávelMetanáliseAnsiedadeEndocanabinoide (não especificado)
  55. 2022

    Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review

    DesfavorávelMetanáliseDorInflamaçãoAnsiedade+10
  56. 2022

    Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  57. 2022

    Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

  58. 2022

    Cannabinoids, Insomnia, and Other Sleep Disorders

    InconclusivoMetanáliseCanabinol (CBN)
  59. 2022

    Cannabis dosing and administration for sleep: a systematic review

    InconclusivoMetanálise ClínicaTetraidrocanabinol (THC)
  60. 2022

    Cannabis in Palliative Care: A Systematic Review of Current Evidence

    InconclusivoMetanáliseCâncerEpilepsiaNáusea e Vômito+6
  61. 2022

    Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review

    DesfavorávelMetanálise ClínicaDorInflamaçãoAnsiedadeAnandamida (AEA)Endocanabinoide (não especificado)+5
  62. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  63. 2022

    Cannabis use as a moderator of cognitive behavioral therapy for insomnia

    InconclusivoEnsaio Clínico Duplo-Cego
  64. 2022

    Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review

    FavorávelMetanálise
  65. 2022

    Capgras Syndrome Due to Cannabinoids Use: A Case Report With Radiological Findings

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadePsicose+1
  66. 2022

    Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

  67. 2022

    Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

    FavorávelEnsaio ClínicoAnsiedadeDisfunção CognitivaQualidade de Vida
  68. 2022

    Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists

    FavorávelMetanáliseAnsiedadeDepressãoTEPTTHC Farmacêutico+1
  69. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  70. 2022

    Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults With Neuropathic Pain After Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials

    InconclusivoMetanálise ClínicaDorDor — Neuropatia PeriféricaDor — Polineuropatia Inflamatória+1
  71. 2022

    Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

  72. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  73. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  74. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  75. 2022

    E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

    DesfavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+16
  76. 2022

    Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

    InconclusivoEnsaio ClínicoDorDependência — CannabisAnsiedade+4
  77. 2022

    Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry

  78. 2022

    Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap

  79. 2022

    Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials

    FavorávelMetanálise ClínicaDorDor — Crônica
  80. 2022

    Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap

  81. 2022

    Geraniol enhances inhibitory inputs to the paraventricular thalamic nucleus and induces sedation in mice

    FavorávelEstudo em AnimaisEpilepsia
  82. 2022

    Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  83. 2022

    Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review

    FavorávelMetanáliseAnsiedadeDisfunção CognitivaTranstornos de Comportamento+1
  84. 2022

    In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

    FavorávelMetanáliseDorCâncerAnsiedade+14
  85. 2022

    Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder

    FavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)+10
  86. 2022

    Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far

  87. 2022

    Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety

  88. 2022

    Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  89. 2022

    Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

  90. 2022

    Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials

    FavorávelMetanálise ClínicaDorDor — Crônica
  91. 2022

    Medical Marijuana Efficacy: A Survey

    FavorávelMetanáliseDorInflamaçãoAnsiedade+3
  92. 2022

    Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)THC:CBD Farmacêutico
  93. 2022

    Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

  94. 2022

    Orchestration of the circadian clock and its association with Alzheimer's disease: Role of endocannabinoid signaling

  95. 2022

    Parkinson’s Disease and Dementia with Lewy Bodies, Patients Under Treatment with Standardized Extracts Enriched in Cannabidiol and Cannabigerol: Descriptive Observations in Preparation for a Phase 2a Clinical Trial

    FavorávelMetanáliseDorAnsiedadePsicoseTetraidrocanabinol (THC)Canabigerol (CBG)+3
  96. 2022

    Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health

  97. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  98. 2022

    Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study

    FavorávelEnsaio ClínicoDorAnsiedadeDor — Crônica+2
  99. 2022

    Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis

    FavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+7
  100. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+12
  101. 2022

    Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada

    FavorávelMetanáliseDorDor — CrônicaDepressão+5
  102. 2022

    Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

  103. 2022

    Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+3
  104. 2022

    Role of Cannabinoids in Various Diseases: A Review

  105. 2022

    Sleep time differs among people who co-use cocaine and cannabis compared to people who only use cocaine

  106. 2022

    Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report

  107. 2022

    The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial

    InconclusivoEnsaio Clínico Duplo-CegoDoença de ParkinsonApneia do SonoSíndrome das Pernas Inquietas
  108. 2022

    The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+7
  109. 2022

    The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study

    FavorávelEnsaio ClínicoDorAnsiedadeDor — Crônica+3
  110. 2022

    The Effects of Cannabinoids on Sleep

    InconclusivoMetanálise
  111. 2022

    The intersection between integrative medicine and neuropathic pain: A case report

  112. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  113. 2022

    Tonic endocannabinoid signaling supports sleep through development in both sexes

    FavorávelEstudo em AnimaisAnandamida (AEA)Endocanabinoide (não especificado)+2
  114. 2022

    Topical Cannabidiol (CBD) After Total Knee Arthroplasty Does Not Decrease Pain or Opioid Use: A Prospective Randomized Double-Blinded Placebo-Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaDependência — Opioides+1
  115. 2022

    Updates in the use of cannabis for insomnia

    InconclusivoMetanáliseSíndrome das Pernas Inquietas
  116. 2021

    A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadePsicose
  117. 2021

    A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisTEPT
  118. 2021

    A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão+5
  119. 2021

    A scoping review of the use of cannabidiol in psychiatric disorders

    FavorávelMetanálise ClínicaDependência — CannabisAnsiedadePsicose+4
  120. 2021

    A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+1
  121. 2021

    Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

    FavorávelMetanáliseDorDependência QuímicaInflamação+7
  122. 2021

    Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite

  123. 2021

    Assessments and Interventions for Sleep Disorders in Infants With or at High Risk for Cerebral Palsy: A Systematic Review

    InconclusivoMetanáliseParalisia CerebralTHC FarmacêuticoCBD Farmacêutico
  124. 2021

    Cancer patient's attitudes of using medicinal cannabis for sleep

    FavorávelMetanáliseCâncer
  125. 2021

    Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome

  126. 2021

    Cannabidiol and Neurodevelopmental Disorders in Children

  127. 2021

    Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder

    FavorávelMetanáliseAnsiedadeTEPTAnandamida (AEA)
  128. 2021

    Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder

    FavorávelEnsaio Clínico Duplo-CegoDoença de ParkinsonTranstorno Comportamental do Sono REM
  129. 2021

    Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaInflamaçãoDependência — CannabisAnandamida (AEA)+8
  130. 2021

    Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain

    FavorávelMetanáliseDorEfeitos Adversos da CannabisAnsiedade+8
  131. 2021

    Cannabinoid control of hippocampal functions: the where matters

  132. 2021

    Cannabinoids and bladder symptoms in multiple sclerosis

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+4
  133. 2021

    Cannabinoids for the treatment of dementia

  134. 2021

    Cannabinol and Sleep: Separating Fact from Fiction

    InconclusivoMetanáliseCanabinol (CBN)
  135. 2021

    Cannabis consumption in young adults with cancer: descriptive study

    FavorávelMetanáliseDorCâncerAnsiedade+3
  136. 2021

    Cannabis sativa Linnaeus as traditional phytomedicine by folk medicine practitioners of Bangladesh

    FavorávelMetanáliseCâncerDoenças Cardiovasculares (DCV)Artrite+4
  137. 2021

    Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study

    InconclusivoEnsaio ClínicoCâncerEpilepsiaNáusea e Vômito+3
  138. 2021

    Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?

    FavorávelEnsaio ClínicoCâncerEsclerose MúltiplaArtrite+1
  139. 2021

    Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom - analysis from the UK Medical Cannabis Registry

    FavorávelMetanáliseDorDor — Crônica
  140. 2021

    Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101

    DesfavorávelEstudo em AnimaisDorInflamaçãoEfeitos Adversos da Cannabis+5
  141. 2021

    Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?

    FavorávelMetanáliseAnsiedadeDepressãoTEPT+1
  142. 2021

    Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  143. 2021

    Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis

  144. 2021

    Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals

    FavorávelMetanálise
  145. 2021

    Effects of Cannabis Consumption on Sleep

    InconclusivoMetanálise
  146. 2021

    Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study

    InconclusivoEstudo Laboratorial
  147. 2021

    Essential Oil from the Leaves of Chromolaena odorata, and Sesquiterpene Caryophyllene Oxide Induce Sedative Activity in Mice

    InconclusivoEstudo em AnimaisOutros Compostos Relacionados
  148. 2021

    Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

    FavorávelMetanáliseDorDor — CrônicaArtrite+3
  149. 2021

    Exploring the Relationship Between ADHD Symptoms and Daily Cannabis Consequences in Emerging Adulthood: The Role of Cannabis Motives

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisTranstornos de ComportamentoTDA e TDAH
  150. 2021

    Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients

    FavorávelMetanáliseDorCâncerNáusea e Vômito+1
  151. 2021

    Healing of a Chronic Pressure Injury in a Patient Treated With Medical Cannabis for Pain and Sleep Improvement: A Case Report

    FavorávelMetanáliseDorDor — CrônicaCicatrização+1
  152. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  153. 2021

    Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study

    FavorávelEnsaio ClínicoDorAnsiedadeDor — CrônicaCBD Farmacêutico+3
  154. 2021

    In vivo brain levels of acetylcholine and 5-hydroxytryptamine after oleoylethanolamide or palmitoylethanolamide administrations are mediated by PPARα engagement

    FavorávelEstudo em AnimaisPalmitoiletanolamida (PEA)Virodamina (O-AEA)
  155. 2021

    Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey

    FavorávelMetanáliseDorCâncerNáusea e Vômito+2
  156. 2021

    Marijuana use and sleep quality during pregnancy

    InconclusivoEnsaio ClínicoGestação
  157. 2021

    Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review

  158. 2021

    Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?

    InconclusivoMetanáliseDorCâncerAnsiedade+5
  159. 2021

    Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials

    InconclusivoMetanálise ClínicaDorDor — CrônicaDor — Oncológica
  160. 2021

    Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects

    FavorávelMetanáliseDorCâncerAnsiedade+5
  161. 2021

    Medicinal applications of cannabis/cannabinoids

    InconclusivoMetanáliseDorEpilepsiaCBD Farmacêutico
  162. 2021

    Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  163. 2021

    Natural Cannabinoids as Templates for Sleep Disturbances Treatments

    FavorávelMetanálise
  164. 2021

    No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms

    FavorávelMetanáliseDorAnsiedadeDor — Crônica
  165. 2021

    Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides+3
  166. 2021

    Pain Profiles among Young Adult Cannabis Users: An Analysis of Antecedent Factors and Distal Outcomes

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda
  167. 2021

    Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

    FavorávelEnsaio Clínico Duplo-CegoPalmitoiletanolamida (PEA)
  168. 2021

    Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer

    FavorávelMetanáliseDorCâncerDor — Crônica+7
  169. 2021

    Potential Role of Cannabidiol on Sports Recovery: A Narrative Review

    FavorávelMetanáliseDorAnsiedadeDisfunção Cognitiva+2
  170. 2021

    Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  171. 2021

    Prospects for the Use of Cannabinoids in Psychiatric Disorders

    InconclusivoMetanáliseAnsiedadeDepressãoDemência
  172. 2021

    Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems

    FavorávelMetanáliseAnsiedade
  173. 2021

    Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users

    InconclusivoMetanáliseAnsiedadeEstresse Oxidativo
  174. 2021

    Sedative effects of l-menthol, d-camphor, phenylethyl alcohol, and geraniol

    FavorávelEstudo em AnimaisAnsiedade
  175. 2021

    Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

    FavorávelEnsaio ClínicoEpilepsiaTranstornos de ComportamentoCBD Farmacêutico
  176. 2021

    Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence

    DesfavorávelEnsaio Clínico
  177. 2021

    Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms

    FavorávelMetanáliseDorAnsiedadeDor — CrônicaCanabigerol (CBG)+1
  178. 2021

    The Effect of Cannabinoids on the Brain's Circadian Clock

    InconclusivoMetanálise
  179. 2021

    The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — Cannabis
  180. 2021

    The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+8
  181. 2021

    The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review

    InconclusivoMetanáliseDorAnsiedadeDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+2
  182. 2021

    The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study

    FavorávelMetanálise
  183. 2021

    Treating Insomnia Symptoms with Medicinal Cannabis: A Randomized, Cross-Over Trial of the Efficacy of a Cannabinoid Medicine Compared with Placebo

    FavorávelEnsaio Clínico Duplo-Cego
  184. 2021

    Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  185. 2020

    A Literature Analysis on Medicinal Use and Research of Cannabis in the Meiji Era of Japan

    FavorávelMetanáliseDorDor — CrônicaDoenças Neurodegenerativas+3
  186. 2020

    A Little Dab Will Do: A Case of Cannabis-Induced Psychosis

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+4
  187. 2020

    Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoTOCTetraidrocanabinol (THC)Endocanabinoide (não especificado)
  188. 2020

    Adult attention-deficit hyperactivity disorder and clinical correlates of delayed sleep phase disorder

    DesfavorávelEnsaio ClínicoTranstornos de ComportamentoTDA e TDAH
  189. 2020

    Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

    DesfavorávelEnsaio Clínico Duplo-Cego
  190. 2020

    Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

    FavorávelMetanáliseDorInflamaçãoAnsiedade+6
  191. 2020

    Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies

    InconclusivoMetanálise
  192. 2020

    Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis

    FavorávelMetanálise Clínica
  193. 2020

    Cannabinoids, Endocannabinoids and Sleep

    InconclusivoMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  194. 2020

    Cannabis use is associated with greater total sleep time in middle-aged and older adults with and without HIV: A preliminary report utilizing digital health technologies

    FavorávelMetanáliseHIV/AIDS
  195. 2020

    Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overweight, But Otherwise Healthy Subjects

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Estresse OxidativoObesidade+2
  196. 2020

    Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals

    FavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+6
  197. 2020

    Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDepressãoFibromialgiaCanabigerol (CBG)Canabinol (CBN)+3
  198. 2020

    Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study

    InconclusivoMetanáliseDorDor — Crônica
  199. 2020

    Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

    FavorávelMetanáliseAnsiedadeDepressãoPsicose+3
  200. 2020

    Medicinal Use of Cannabis in Children and Pregnant Women

    FavorávelMetanáliseAnsiedadeDependência — ÁlcoolNáusea e Vômito+5
  201. 2020

    Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

  202. 2020

    Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats

  203. 2020

    Small bowel intussusception in marijuana users

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+6
  204. 2020

    The Endocannabinoid System May Modulate Sleep Disorders in Aging

  205. 2019

    A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoPalmitoiletanolamida (PEA)
  206. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

  207. 2019

    A systematic review of cannabidiol dosing in clinical populations

    FavorávelMetanálise ClínicaDorDependência — CannabisAnsiedade+14
  208. 2019

    Acute effect of vaporized Cannabis on sleep and electrocortical activity

    FavorávelEstudo em Animais
  209. 2019

    Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms

    FavorávelMetanáliseDorAnsiedadeDepressão+4
  210. 2019

    Cannabidiol Adverse Effects and Toxicity

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e Vômito
  211. 2019

    Cannabidiol in Anxiety and Sleep: A Large Case Series

    FavorávelMetanáliseAnsiedade
  212. 2019

    Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

    FavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+3
  213. 2019

    Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats: Preliminary data

    FavorávelEstudo em Animais
  214. 2019

    Cannabis Expectancies for Sleep

    FavorávelMetanálise
  215. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

  216. 2019

    Naturally occurring compounds as pancreatic cancer therapeutic

    FavorávelMetanáliseDorCâncerDor — Oncológica+2
  217. 2019

    Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring Health-Related Quality of Life Symptoms

    FavorávelMetanáliseDorAnsiedadeDepressão
  218. 2019

    Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

    DesfavorávelMetanáliseEfeitos Adversos da CannabisInfecções BacterianasCaquexia
  219. 2019

    Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis

  220. 2019

    The use of cannabinoids for sleep: A critical review on clinical trials

  221. 2019

    Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

    FavorávelMetanáliseAnsiedadeDepressãoEpilepsia+3
  222. 2019

    Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary

    FavorávelMetanáliseDorDor — Crônica
  223. 2019

    Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado

    FavorávelMetanálise
  224. 2018

    A Cross-Sectional Study of Cannabidiol Users

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  225. 2018

    A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms

  226. 2018

    Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

  227. 2018

    Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Estimulantes
  228. 2018

    Cannabinoid-mediated retinal rescue correlates with improved circadian parameters in retinal dystrophic rats.

    FavorávelEstudo em AnimaisDoenças da RetinaCanabinoides Sintéticos HU-x
  229. 2018

    Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults

    FavorávelMetanáliseDorAnsiedadeDepressão+1
  230. 2018

    Endocannabinoid signalling: has it got rhythm?

    FavorávelMetanáliseAnandamida (AEA)
  231. 2018

    Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders

    FavorávelEnsaio ClínicoDoença de ParkinsonParalisia CerebralTetraidrocanabinol (THC)
  232. 2018

    The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorAnorexia (perda de apetite)Dor — OncológicaTHC Farmacêutico+4
  233. 2018

    The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+7
  234. 2017

    Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications

    FavorávelMetanáliseDorAnsiedadeAnorexia (perda de apetite)+2
  235. 2017

    Cannabis, Cannabinoids, and Sleep: a Review of the Literature

  236. 2017

    Efficacy of Silexan in Subthreshold Anxiety: Meta-Analysis of Randomised, Placebo-Controlled Trials

    FavorávelMetanálise ClínicaAnsiedadeDepressão
  237. 2017

    Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life

    FavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+3
  238. 2017

    Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)
  239. 2017

    Substitution Of Medical Cannabis For Pharmaceutical Agents For Pain, Anxiety, And Sleep

    FavorávelMetanáliseDorAnsiedade
  240. 2016

    Cannabinoids in Palliative Care: Systematic Review and Meta-Analysis of Efficacy, Tolerability and Safety

    InconclusivoMetanálise ClínicaDorCâncerNáusea e Vômito+4
  241. 2016

    Effectiveness Of Cannabidiol Oil For Pediatric Anxiety And Insomnia As Part Of Posttraumatic Stress Disorder: A Case Report

    FavorávelMetanáliseAnsiedadeTEPT
  242. 2016

    Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users

  243. 2016

    Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials

  244. 2016

    Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity

    FavorávelEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  245. 2016

    Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol

    InconclusivoEnsaio ClínicoObesidadeSíndrome Metabólica
  246. 2016

    Splendor In The Grass? A Pilot Study Assessing The Impact Of Medical Marijuana On Executive Function

  247. 2016

    α-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice Through GABAA-benzodiazepine Receptors

    FavorávelEstudo em Animais
  248. 2015

    Cannabinoids for Medical Use A Systematic Review and Meta-analysis

    FavorávelMetanáliseDorDor — CrônicaCaquexia+2
  249. 2015

    Cannabis withdrawal and sleep: A systematic review of human studies

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — Cannabis
  250. 2015

    Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep – A randomized, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  251. 2015

    Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorCâncerNáusea e VômitoTHC Farmacêutico+5
  252. 2015

    MDMA, cannabis, and cocaine produce acute dissociative symptoms

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisAnsiedade+7
  253. 2015

    The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  254. 2015

    Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

    FavorávelMetanáliseDorCâncerDoenças Cardiovasculares (DCV)+9
  255. 2014

    A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  256. 2014

    Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series.

    FavorávelMetanáliseDoença de ParkinsonTranstorno Comportamental do Sono REM
  257. 2014

    How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDependência — CannabisAnsiedadeTHC Farmacêutico+4
  258. 2014

    Potential Effects of Cannabidiol as a Wake-Promoting Agent.

    FavorávelMetanálise
  259. 2014

    Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder

    FavorávelEnsaio ClínicoDependência — CannabisTEPTTetraidrocanabinol (THC)
  260. 2013

    Around‐the‐clock oral THC effects on sleep in male chronic daily cannabis smokers.

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  261. 2013

    Characterization of Anxiolytic and Neuropharmacological Activities of Silexan

    FavorávelEstudo em AnimaisAnsiedade
  262. 2013

    Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.

    FavorávelEstudo em Animais
  263. 2012

    A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  264. 2012

    An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics

  265. 2012

    Antidepressant activity of Litsea glaucescens essential oil: Identification of β-pinene and linalool as active principles

    FavorávelEstudo LaboratorialDorAnsiedadeDepressãoMedicina Mente-Corpo+6
  266. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  267. 2012

    Multiple sclerosis and extract of cannabis: results of the MUSEC trial

    FavorávelEnsaio Clínico Duplo-CegoDorEsclerose Múltipla
  268. 2012

    Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerDor — CrônicaTHC:CBD Farmacêutico+2
  269. 2011

    A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

  270. 2011

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerInflamaçãoTHC Farmacêutico+9
  271. 2011

    Sedative effects of vapor inhalation of the essential oil of Microtoena patchoulii and its related compounds

    FavorávelEstudo em Animais
  272. 2011

    Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

  273. 2010

    Silexan, an Orally Administered Lavandula Oil Preparation, Is Effective in the Treatment of 'Subsyndromal' Anxiety Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  274. 2009

    The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial.

    FavorávelEnsaio Clínico Duplo-CegoFibromialgia
  275. 2008

    Inhaled linalool-induced sedation in mice.

    FavorávelEstudo em AnimaisAnsiedadeEpilepsia
  276. 2008

    Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain

    FavorávelEnsaio ClínicoDorDor — CrônicaPerda de ApetiteTetraidrocanabinol (THC)+2
  277. 2008

    The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent

    FavorávelEstudo em Animais
  278. 2007

    Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

  279. 2005

    Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

  280. 2005

    Survey of Australians using cannabis for medical purposes

    FavorávelMetanáliseDorDor — CrônicaDepressão+3
  281. 2003

    Behavioral and subjective effects of marijuana following partial sleep deprivation

    InconclusivoEnsaio ClínicoEfeitos Adversos da Cannabis
  282. 2003

    Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)
  283. 2002

    Central Effects of Citral, Myrcene and Limonene, Constituents of Essential Oil Chemotypes From Lippia Alba (Mill.) n.e. Brown

    FavorávelEstudo em AnimaisAnsiedadeMedicina Mente-Corpo
  284. 1998

    Anandamida modulates sleep and memory in rats.

    FavorávelEstudo em AnimaisAnandamida (AEA)Outros Compostos Relacionados
  285. 1982

    The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers.

    FavorávelEnsaio Clínico Duplo-Cego
  286. 1981

    Hypnotic And Antiepileptic Effects Of Cannabidiol

    FavorávelMetanálise ClínicaEpilepsiaEpilepsia — Síndrome de DravetEpilepsia — Lennox-Gastaut
  287. 1978

    Toward drugs derived from Cannabis

  288. 1977

    Hypnoticlike effects of cannabidiol in the rat

    FavorávelEstudo em Animais
  289. 1976

    Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns

    FavorávelEnsaio ClínicoCanabinol (CBN)
  290. 1975

    Effect of chronic marijuana administration of stages of primate sleep-wakefulness.

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)
  291. 1975

    Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man.

    FavorávelEnsaio Clínico
  292. 1973

    Δ9-Tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)
  293. 1918

    Dispensatory of the United States, 20th ed. (1918)

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+4
  294. 1890

    Cannabis Indica

    FavorávelMetanáliseDorDor — CrônicaDoença de Alzheimer+6
  295. 1843

    Observations on the medicinal properties of the Cannabis Sativa of India

    FavorávelMetanáliseDorCâncerDepressão+10
  296. 1839

    On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica), Their Effects on the Animal System in Health, and Their Utility in the Treatment of Tetanus and Other Convulsive Diseases

    FavorávelMetanáliseEpilepsiaArtriteAnorexia (perda de apetite)+7

Continue por aqui

Perguntas frequentes

Quantos estudos sobre insônia e distúrbios do sono estão indexados no acervo?
São 296 estudos, publicados entre 1839 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 147 · Ensaio Clínico: 46 · Ensaio Clínico Duplo-Cego: 45 · Metanálise Clínica: 29 · Estudo em Animais: 24 · Estudo Laboratorial: 5. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 216 favoráveis, 46 inconclusivos e 34 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Insônia e Distúrbios do Sono — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/insonia-e-disturbios-do-sono/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Insônia e Distúrbios do Sono — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/insonia-e-disturbios-do-sono/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.